Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 1997

View Archived Issues

Potent and selective dopamine D3 ligands from ADIR

Kyowa Hakko discovers inhibitors of IL-1beta production

ET antagonists claimed by Bristol-Myers Squibb

Roche describes endothelin antagonists

Antioxidant diester reported by Senju

Novel, irreversible HIV protease inhibitor disclosed by LG Chemical

Human PEP inhibitor isolated from microbial sources

Tokyo Tanabe developing oxytocin antagonist

Full 5-HT1A receptor antagonist described by Duphar

Synthesis and pharmacological profile of new antithrombotic pentasaccharide

Pharmacological profile of BMS-186716 characterized

Abelcet approved in Canada

Corvas to strengthen anticancer program with option to acquire Vascular Genomics

New immunoassay for DVT diagnosis

CoCensys reports on phase II trial with ganaxolone

Topical t-PA for the treatment of venous ulcers

Celtrix's SomatoKine enters phase II feasibility study for the treatment of burns

Injectable microsphere-encapsulated norethindrone is a safe and effective contraceptive

Edex cleared for erectile dysfunction in the U.S.

Nycomed and Amersham announce proposed merger

Sepracor submits first NDA for levalbuterol

Shire acquires distribution rights for Urispas from Recordati

Oncogene Science and Xenometrix alliance for drug discovery/lead optimization technologies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...